HCW Biologics issues 400,000 pre-funded warrants in $1.6 million private placement

A registration rights agreement calls for an S-1 filing within 15 trading days of closing to register resale shares, including warrant shares.

HCW Biologics priced a $1.6 million private placement with 618,682 units tied to common stock purchase warrants.

The deal includes 400,000 pre-funded warrants exercisable immediately at $0.0001 per share, with no expiration until fully exercised.

Investors will receive common warrants to buy up to 618,682 shares, subject to stockholder approval; the exercise price is $2.59 and the term is 5.5 years.